State Street Corp Bridge Bio Pharma, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, State Street Corp holds 5,962,654 shares of BBIO stock, worth $158 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,962,654

Previous 5,854,140 1.85%

Holding current value

$158 Million

Previous $148 Million 2.38%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$23.91 - $31.3 $2.59 Million - $3.4 Million	108,514 Added 1.85%	5,962,654 $152 Million
Q2 2024 Aug 14, 2024	BUY	$23.0 - $31.04 $10.6 Million - $14.3 Million	461,278 Added 8.55%	5,854,140 $148 Million
Q1 2024 May 15, 2024	BUY	$27.35 - $40.45 $8.37 Million - $12.4 Million	305,963 Added 6.01%	5,392,862 $167 Million
Q4 2023 Feb 14, 2024	BUY	$24.02 - $43.89 $1.12 Million - $2.04 Million	46,485 Added 0.92%	5,086,899 $205 Million
Q3 2023 Nov 14, 2023	SELL	$16.89 - $35.01 $34.3 Million - $71 Million	-2,028,946 Reduced 28.7%	5,040,414 $133 Million
Q2 2023 Aug 14, 2023	BUY	$13.29 - $18.01 $25.6 Million - $34.7 Million	1,926,347 Added 37.46%	7,069,360 $122 Million
Q1 2023 May 15, 2023	SELL	$7.17 - $18.55 $26.5 Million - $68.7 Million	-3,701,930 Reduced 41.85%	5,143,013 $85.3 Million
Q4 2022 Feb 14, 2023	BUY	$6.74 - $11.52 $6.08 Million - $10.4 Million	902,132 Added 11.36%	8,844,943 $67.4 Million
Q3 2022 Nov 15, 2022	SELL	$7.94 - $12.36 $23.9 Million - $37.3 Million	-3,014,252 Reduced 27.51%	7,942,811 $79 Million
Q2 2022 Aug 15, 2022	BUY	$5.21 - $12.14 $9.12 Million - $21.3 Million	1,750,829 Added 19.02%	10,957,063 $99.5 Million
Q1 2022 May 16, 2022	BUY	$7.34 - $17.16 $41.7 Million - $97.5 Million	5,683,771 Added 161.36%	9,206,234 $93.4 Million
Q4 2021 Feb 14, 2022	BUY	$11.38 - $53.41 $4.99 Million - $23.4 Million	438,604 Added 14.22%	3,522,463 $58.8 Million
Q3 2021 Nov 15, 2021	BUY	$46.87 - $64.24 $20.2 Million - $27.6 Million	430,363 Added 16.22%	3,083,859 $145 Million
Q2 2021 Aug 16, 2021	BUY	$46.47 - $63.93 $13.4 Million - $18.4 Million	288,124 Added 12.18%	2,653,496 $162 Million
Q1 2021 May 17, 2021	BUY	$55.47 - $72.35 $3.82 Million - $4.98 Million	68,849 Added 3.0%	2,365,372 $146 Million
Q4 2020 Feb 16, 2021	SELL	$38.38 - $71.11 $2.23 Million - $4.12 Million	-57,985 Reduced 2.46%	2,296,523 $163 Million
Q3 2020 Nov 10, 2020	SELL	$27.2 - $42.19 $22.6 Million - $35.1 Million	-831,813 Reduced 26.11%	2,354,508 $88.3 Million
Q2 2020 Aug 14, 2020	BUY	$22.22 - $35.69 $32.7 Million - $52.6 Million	1,472,605 Added 85.93%	3,186,321 $104 Million
Q1 2020 May 11, 2020	BUY	$16.11 - $36.23 $27.6 Million - $62.1 Million	1,713,716 New	1,713,716 $49.7 Million

Others Institutions Holding BBIO

# of Institutions

290

Shares Held

170M

Call Options Held

10.4M

Put Options Held

2.37M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.93B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Bridge Bio Pharma, Inc. Transaction History